Glaukos Corporation 6GJ.F Stock
Glaukos Corporation Price Chart
Glaukos Corporation 6GJ.F Financial and Trading Overview
| Glaukos Corporation stock price | 91.5 EUR |
| Previous Close | 61.5 EUR |
| Open | 61.5 EUR |
| Bid | 61.5 EUR x 30000 |
| Ask | 62 EUR x 30000 |
| Day's Range | 61.5 - 61.5 EUR |
| 52 Week Range | 38.2 - 63 EUR |
| Volume | 190 EUR |
| Avg. Volume | 33 EUR |
| Market Cap | 3B EUR |
| Beta (5Y Monthly) | 1.227112 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.59 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 51.67 EUR |
6GJ.F Valuation Measures
| Enterprise Value | 3.03B EUR |
| Trailing P/E | N/A |
| Forward P/E | -43.006996 |
| PEG Ratio (5 yr expected) | -9.23 |
| Price/Sales (ttm) | 10.380625 |
| Price/Book (mrq) | 5.7980576 |
| Enterprise Value/Revenue | 10.477 |
| Enterprise Value/EBITDA | -36.566 |
Trading Information
Glaukos Corporation Stock Price History
| Beta (5Y Monthly) | 1.227112 |
| 52-Week Change | 47.12% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 63 EUR |
| 52 Week Low | 38.2 EUR |
| 50-Day Moving Average | 49.65 EUR |
| 200-Day Moving Average | 48.32 EUR |
6GJ.F Share Statistics
| Avg. Volume (3 month) | 33 EUR |
| Avg. Daily Volume (10-Days) | 19 EUR |
| Shares Outstanding | 48.21M |
| Float | 46.36M |
| Short Ratio | N/A |
| % Held by Insiders | 3.85% |
| % Held by Institutions | 99.42% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -48.15% |
| Operating Margin (ttm) | -39.81% |
| Gross Margin | 75.79% |
| EBITDA Margin | -28.65% |
Management Effectiveness
| Return on Assets (ttm) | -7.10% |
| Return on Equity (ttm) | -25.16% |
Income Statement
| Revenue (ttm) | 289.08M EUR |
| Revenue Per Share (ttm) | 6.07 EUR |
| Quarterly Revenue Growth (yoy) | 9.19% |
| Gross Profit (ttm) | 213.88M EUR |
| EBITDA | -82826000 EUR |
| Net Income Avi to Common (ttm) | -139198000 EUR |
| Diluted EPS (ttm) | -2.69 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 317.77M EUR |
| Total Cash Per Share (mrq) | 6.6 EUR |
| Total Debt (mrq) | 383.24M EUR |
| Total Debt/Equity (mrq) | 75.37 EUR |
| Current Ratio (mrq) | 6.666 |
| Book Value Per Share (mrq) | 10.607 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -73621000 EUR |
| Levered Free Cash Flow (ttm) | -46998248 EUR |
Profile of Glaukos Corporation
| Country | Germany |
| State | CA |
| City | Aliso Viejo |
| Address | One Glaukos Way |
| ZIP | 92656 |
| Phone | 949 367 9600 |
| Website | https://www.glaukos.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 783 |
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, an implantable device intended to reduce the intraocular pressure of the eye; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo California.
Q&A For Glaukos Corporation Stock
What is a current 6GJ.F stock price?
Glaukos Corporation 6GJ.F stock price today per share is 91.5 EUR.
How to purchase Glaukos Corporation stock?
You can buy 6GJ.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Glaukos Corporation?
The stock symbol or ticker of Glaukos Corporation is 6GJ.F.
Which industry does the Glaukos Corporation company belong to?
The Glaukos Corporation industry is Medical Devices.
How many shares does Glaukos Corporation have in circulation?
The max supply of Glaukos Corporation shares is 49.51M.
What is Glaukos Corporation Price to Earnings Ratio (PE Ratio)?
Glaukos Corporation PE Ratio is now.
What was Glaukos Corporation earnings per share over the trailing 12 months (TTM)?
Glaukos Corporation EPS is -2.59 EUR over the trailing 12 months.
Which sector does the Glaukos Corporation company belong to?
The Glaukos Corporation sector is Healthcare.